Analogifremgangsmåde til fremstilling af 3α-oxygenerede pregn-4-en-20-oner
1372175 3α-Hydroxy-pregn-4-enes and their esters GLAXO LABORATORIES Ltd 5 Nov 1971 [6 Nov 1970] 53038/70 Heading C2U [Also in Division A5] Novel pregn-4-enes and 19-nor-pregn-4-enes, excluding 3α-hydroxypregn-4-en-20-one, possess a 3α-(free or esterified hydroxy group) group, a 17#-acetyl group toge...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | dan |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | GORDON IAN GREGORY NIALL GALBRAITH WEIR |
description | 1372175 3α-Hydroxy-pregn-4-enes and their esters GLAXO LABORATORIES Ltd 5 Nov 1971 [6 Nov 1970] 53038/70 Heading C2U [Also in Division A5] Novel pregn-4-enes and 19-nor-pregn-4-enes, excluding 3α-hydroxypregn-4-en-20-one, possess a 3α-(free or esterified hydroxy group) group, a 17#-acetyl group together with a 17α-hydrogen atom, and in the 11-position two hydrogen atoms or an oxo group. The esterified hydroxy group is derived from an optionally carboxy- or halosubstituted C 1-5 alkanoic acid. The steroids may contain further substituents in undefined positions, particularly in the 2- and 16- positions, e.g. 16-CH 3 and 2#-(alkyl, alkoxy and halo). They may be prepared, for example, (a) by nucleophilic displacement of an allylically replaceable 3#-substituent in a suitable steroid containing a 2#-hydrogen atom by the required 3α-(free or esterified hydroxy group); or (b) for a product containing a 2#-substituent, by reacting an appropriate 2α,3α-epoxy-5α-ol with R2H (R2 is C 1-5 alkyl, C 1-6 alkoxy or halogen) or a compound furnishing an anion R2- and a cation to give the corresponding 2#-R2-3α-ol (or a metal salt thereof) followed by treatment with a proton source when necessary and then dehydration to form the #4-double bond, the 3α-OH group being protected during dehydration and subsequently released. Resulting 3α-ols may subsequently be esterified. In one example 3#-dichloroacetoxypregn-4-en- 20-one (prepared from the free 3#-ol and dichloroacetyl chloride) is refluxed with an acetate buffer solution to give, in addition to the required 3α-ol, some 3#-hydrozy-pregn-4-en-20-one and 5α - hydroxy - pregn - 3 - en - 20 - one; the last-mentioned is separated from the 3α-ol by preparative T.L.C. and the 3#- and 3α-ols, and other similarly formed 3α- and 3#-ol mixtures, are separated via the digitonin complexes of the 3#-ols. In another example dehydration of 3α- acetoxy - 5α - hydroxy - 2# - methoxypregnan- 20-one gives not only the required #4-compound but also 3α-acetoxy-2#-methoxypregn-5-en-20- one. 3# - Hydroxypregn - 4 - ene - 11,20 - dione is prepared by converting 3-[pyrrolidin-1-yl)- pregna -3,5 - dien - 11,20 - dione (prepared from 11-oxo-progesterone and pyrrolidine) to the enaminium chloride, reacting this with ethyleneglycol and hydrolysing to give 20,20-ethylenedioxypregn - 4 - ene - 3,11 - dione, reducing this to 20,20-ethylenedioxy-3#-hydroxypregn-4- en-11-one and'hydrolysing this; the intermediate 3,11-dione may alternatively be prepared by ox |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK128898BB</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK128898BB</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK128898BB3</originalsourceid><addsrcrecordid>eNrjZPBxzEvMyU_PTCtKzU1PzEsvzj28NCVVoSQzRwEkVAxk5GTmpSskpikYn9uom19RmZ6al1qUClRTUJSanqdropuap2tkoJsPFOVhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJQL0l8S7ehkYWFpYWTk7GhFUAAFCKNdc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Analogifremgangsmåde til fremstilling af 3α-oxygenerede pregn-4-en-20-oner</title><source>esp@cenet</source><creator>GORDON IAN GREGORY ; NIALL GALBRAITH WEIR</creator><creatorcontrib>GORDON IAN GREGORY ; NIALL GALBRAITH WEIR</creatorcontrib><description>1372175 3α-Hydroxy-pregn-4-enes and their esters GLAXO LABORATORIES Ltd 5 Nov 1971 [6 Nov 1970] 53038/70 Heading C2U [Also in Division A5] Novel pregn-4-enes and 19-nor-pregn-4-enes, excluding 3α-hydroxypregn-4-en-20-one, possess a 3α-(free or esterified hydroxy group) group, a 17#-acetyl group together with a 17α-hydrogen atom, and in the 11-position two hydrogen atoms or an oxo group. The esterified hydroxy group is derived from an optionally carboxy- or halosubstituted C 1-5 alkanoic acid. The steroids may contain further substituents in undefined positions, particularly in the 2- and 16- positions, e.g. 16-CH 3 and 2#-(alkyl, alkoxy and halo). They may be prepared, for example, (a) by nucleophilic displacement of an allylically replaceable 3#-substituent in a suitable steroid containing a 2#-hydrogen atom by the required 3α-(free or esterified hydroxy group); or (b) for a product containing a 2#-substituent, by reacting an appropriate 2α,3α-epoxy-5α-ol with R2H (R2 is C 1-5 alkyl, C 1-6 alkoxy or halogen) or a compound furnishing an anion R2- and a cation to give the corresponding 2#-R2-3α-ol (or a metal salt thereof) followed by treatment with a proton source when necessary and then dehydration to form the #4-double bond, the 3α-OH group being protected during dehydration and subsequently released. Resulting 3α-ols may subsequently be esterified. In one example 3#-dichloroacetoxypregn-4-en- 20-one (prepared from the free 3#-ol and dichloroacetyl chloride) is refluxed with an acetate buffer solution to give, in addition to the required 3α-ol, some 3#-hydrozy-pregn-4-en-20-one and 5α - hydroxy - pregn - 3 - en - 20 - one; the last-mentioned is separated from the 3α-ol by preparative T.L.C. and the 3#- and 3α-ols, and other similarly formed 3α- and 3#-ol mixtures, are separated via the digitonin complexes of the 3#-ols. In another example dehydration of 3α- acetoxy - 5α - hydroxy - 2# - methoxypregnan- 20-one gives not only the required #4-compound but also 3α-acetoxy-2#-methoxypregn-5-en-20- one. 3# - Hydroxypregn - 4 - ene - 11,20 - dione is prepared by converting 3-[pyrrolidin-1-yl)- pregna -3,5 - dien - 11,20 - dione (prepared from 11-oxo-progesterone and pyrrolidine) to the enaminium chloride, reacting this with ethyleneglycol and hydrolysing to give 20,20-ethylenedioxypregn - 4 - ene - 3,11 - dione, reducing this to 20,20-ethylenedioxy-3#-hydroxypregn-4- en-11-one and'hydrolysing this; the intermediate 3,11-dione may alternatively be prepared by oxidation of 20, 20-ethylenedioxy-11α-hydroxypregn-4-en-3-one, in turn prepared by converting 11α - hydroxypregn - 4 - ene - 3,20 - dione to 11α - hydroxy - 3 - (pyrrolidin - 1 - yl) - pregna- 3,5-dien-20-one, converting this to the enaminiurn chloride and reacting this with ethylene glycol and hydrolysing to the 3-one. 3#-Dichloroacetoxypregn - 4 - ene - 11,20 - dione and 3α - acetoxy - 5α - hydroxy - 2# - methoxypregnan- 20-one are prepared by esterification of the corresponding 3-ols, 3α,5α-dihdroxy-2#-methoxypregn-20-one being in turn prepared from 2α,3α- epoxy-5α-hydroxypregnan-20-one and methanol.</description><edition>2</edition><language>dan</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>1974</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19740722&DB=EPODOC&CC=DK&NR=128898B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19740722&DB=EPODOC&CC=DK&NR=128898B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GORDON IAN GREGORY</creatorcontrib><creatorcontrib>NIALL GALBRAITH WEIR</creatorcontrib><title>Analogifremgangsmåde til fremstilling af 3α-oxygenerede pregn-4-en-20-oner</title><description>1372175 3α-Hydroxy-pregn-4-enes and their esters GLAXO LABORATORIES Ltd 5 Nov 1971 [6 Nov 1970] 53038/70 Heading C2U [Also in Division A5] Novel pregn-4-enes and 19-nor-pregn-4-enes, excluding 3α-hydroxypregn-4-en-20-one, possess a 3α-(free or esterified hydroxy group) group, a 17#-acetyl group together with a 17α-hydrogen atom, and in the 11-position two hydrogen atoms or an oxo group. The esterified hydroxy group is derived from an optionally carboxy- or halosubstituted C 1-5 alkanoic acid. The steroids may contain further substituents in undefined positions, particularly in the 2- and 16- positions, e.g. 16-CH 3 and 2#-(alkyl, alkoxy and halo). They may be prepared, for example, (a) by nucleophilic displacement of an allylically replaceable 3#-substituent in a suitable steroid containing a 2#-hydrogen atom by the required 3α-(free or esterified hydroxy group); or (b) for a product containing a 2#-substituent, by reacting an appropriate 2α,3α-epoxy-5α-ol with R2H (R2 is C 1-5 alkyl, C 1-6 alkoxy or halogen) or a compound furnishing an anion R2- and a cation to give the corresponding 2#-R2-3α-ol (or a metal salt thereof) followed by treatment with a proton source when necessary and then dehydration to form the #4-double bond, the 3α-OH group being protected during dehydration and subsequently released. Resulting 3α-ols may subsequently be esterified. In one example 3#-dichloroacetoxypregn-4-en- 20-one (prepared from the free 3#-ol and dichloroacetyl chloride) is refluxed with an acetate buffer solution to give, in addition to the required 3α-ol, some 3#-hydrozy-pregn-4-en-20-one and 5α - hydroxy - pregn - 3 - en - 20 - one; the last-mentioned is separated from the 3α-ol by preparative T.L.C. and the 3#- and 3α-ols, and other similarly formed 3α- and 3#-ol mixtures, are separated via the digitonin complexes of the 3#-ols. In another example dehydration of 3α- acetoxy - 5α - hydroxy - 2# - methoxypregnan- 20-one gives not only the required #4-compound but also 3α-acetoxy-2#-methoxypregn-5-en-20- one. 3# - Hydroxypregn - 4 - ene - 11,20 - dione is prepared by converting 3-[pyrrolidin-1-yl)- pregna -3,5 - dien - 11,20 - dione (prepared from 11-oxo-progesterone and pyrrolidine) to the enaminium chloride, reacting this with ethyleneglycol and hydrolysing to give 20,20-ethylenedioxypregn - 4 - ene - 3,11 - dione, reducing this to 20,20-ethylenedioxy-3#-hydroxypregn-4- en-11-one and'hydrolysing this; the intermediate 3,11-dione may alternatively be prepared by oxidation of 20, 20-ethylenedioxy-11α-hydroxypregn-4-en-3-one, in turn prepared by converting 11α - hydroxypregn - 4 - ene - 3,20 - dione to 11α - hydroxy - 3 - (pyrrolidin - 1 - yl) - pregna- 3,5-dien-20-one, converting this to the enaminiurn chloride and reacting this with ethylene glycol and hydrolysing to the 3-one. 3#-Dichloroacetoxypregn - 4 - ene - 11,20 - dione and 3α - acetoxy - 5α - hydroxy - 2# - methoxypregnan- 20-one are prepared by esterification of the corresponding 3-ols, 3α,5α-dihdroxy-2#-methoxypregn-20-one being in turn prepared from 2α,3α- epoxy-5α-hydroxypregnan-20-one and methanol.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1974</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPBxzEvMyU_PTCtKzU1PzEsvzj28NCVVoSQzRwEkVAxk5GTmpSskpikYn9uom19RmZ6al1qUClRTUJSanqdropuap2tkoJsPFOVhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJQL0l8S7ehkYWFpYWTk7GhFUAAFCKNdc</recordid><startdate>19740722</startdate><enddate>19740722</enddate><creator>GORDON IAN GREGORY</creator><creator>NIALL GALBRAITH WEIR</creator><scope>EVB</scope></search><sort><creationdate>19740722</creationdate><title>Analogifremgangsmåde til fremstilling af 3α-oxygenerede pregn-4-en-20-oner</title><author>GORDON IAN GREGORY ; NIALL GALBRAITH WEIR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK128898BB3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>1974</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>GORDON IAN GREGORY</creatorcontrib><creatorcontrib>NIALL GALBRAITH WEIR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GORDON IAN GREGORY</au><au>NIALL GALBRAITH WEIR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Analogifremgangsmåde til fremstilling af 3α-oxygenerede pregn-4-en-20-oner</title><date>1974-07-22</date><risdate>1974</risdate><abstract>1372175 3α-Hydroxy-pregn-4-enes and their esters GLAXO LABORATORIES Ltd 5 Nov 1971 [6 Nov 1970] 53038/70 Heading C2U [Also in Division A5] Novel pregn-4-enes and 19-nor-pregn-4-enes, excluding 3α-hydroxypregn-4-en-20-one, possess a 3α-(free or esterified hydroxy group) group, a 17#-acetyl group together with a 17α-hydrogen atom, and in the 11-position two hydrogen atoms or an oxo group. The esterified hydroxy group is derived from an optionally carboxy- or halosubstituted C 1-5 alkanoic acid. The steroids may contain further substituents in undefined positions, particularly in the 2- and 16- positions, e.g. 16-CH 3 and 2#-(alkyl, alkoxy and halo). They may be prepared, for example, (a) by nucleophilic displacement of an allylically replaceable 3#-substituent in a suitable steroid containing a 2#-hydrogen atom by the required 3α-(free or esterified hydroxy group); or (b) for a product containing a 2#-substituent, by reacting an appropriate 2α,3α-epoxy-5α-ol with R2H (R2 is C 1-5 alkyl, C 1-6 alkoxy or halogen) or a compound furnishing an anion R2- and a cation to give the corresponding 2#-R2-3α-ol (or a metal salt thereof) followed by treatment with a proton source when necessary and then dehydration to form the #4-double bond, the 3α-OH group being protected during dehydration and subsequently released. Resulting 3α-ols may subsequently be esterified. In one example 3#-dichloroacetoxypregn-4-en- 20-one (prepared from the free 3#-ol and dichloroacetyl chloride) is refluxed with an acetate buffer solution to give, in addition to the required 3α-ol, some 3#-hydrozy-pregn-4-en-20-one and 5α - hydroxy - pregn - 3 - en - 20 - one; the last-mentioned is separated from the 3α-ol by preparative T.L.C. and the 3#- and 3α-ols, and other similarly formed 3α- and 3#-ol mixtures, are separated via the digitonin complexes of the 3#-ols. In another example dehydration of 3α- acetoxy - 5α - hydroxy - 2# - methoxypregnan- 20-one gives not only the required #4-compound but also 3α-acetoxy-2#-methoxypregn-5-en-20- one. 3# - Hydroxypregn - 4 - ene - 11,20 - dione is prepared by converting 3-[pyrrolidin-1-yl)- pregna -3,5 - dien - 11,20 - dione (prepared from 11-oxo-progesterone and pyrrolidine) to the enaminium chloride, reacting this with ethyleneglycol and hydrolysing to give 20,20-ethylenedioxypregn - 4 - ene - 3,11 - dione, reducing this to 20,20-ethylenedioxy-3#-hydroxypregn-4- en-11-one and'hydrolysing this; the intermediate 3,11-dione may alternatively be prepared by oxidation of 20, 20-ethylenedioxy-11α-hydroxypregn-4-en-3-one, in turn prepared by converting 11α - hydroxypregn - 4 - ene - 3,20 - dione to 11α - hydroxy - 3 - (pyrrolidin - 1 - yl) - pregna- 3,5-dien-20-one, converting this to the enaminiurn chloride and reacting this with ethylene glycol and hydrolysing to the 3-one. 3#-Dichloroacetoxypregn - 4 - ene - 11,20 - dione and 3α - acetoxy - 5α - hydroxy - 2# - methoxypregnan- 20-one are prepared by esterification of the corresponding 3-ols, 3α,5α-dihdroxy-2#-methoxypregn-20-one being in turn prepared from 2α,3α- epoxy-5α-hydroxypregnan-20-one and methanol.</abstract><edition>2</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | dan |
recordid | cdi_epo_espacenet_DK128898BB |
source | esp@cenet |
subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Analogifremgangsmåde til fremstilling af 3α-oxygenerede pregn-4-en-20-oner |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T01%3A42%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GORDON%20IAN%20GREGORY&rft.date=1974-07-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK128898BB%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |